UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

Frontiers in pharmacology, 2023-08, Vol.14, p.1190402-1190402

2023

Volltextzugriff (PDF)

Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency

Molecular neurodegeneration, 2020-03, Vol.15 (1), p.21-19, Article 21

2020

Volltextzugriff (PDF)

Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease

Frontiers in medicine, 2022-10, Vol.9, p.1033272-1033272

2022

Volltextzugriff (PDF)

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

Neurology, 2016-08, Vol.87 (5), p.539-547

2016

Volltextzugriff (PDF)

Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers

NeuroImage clinical, 2018-01, Vol.18, p.591-598

2018

Volltextzugriff (PDF)

Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features

Neurology, 2019-08, Vol.93 (8), p.e778

2019

Volltextzugriff (PDF)

Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression: A Two-Step Pilot Study

Alzheimer disease and associated disorders, 2023-04, Vol.37 (2), p.145

2023

Volltextzugriff (PDF)

Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults

Neurology, 2020-10, Vol.95 (16), p.e2295

2020

Volltextzugriff (PDF)

Asian Cohort for Alzheimer Disease (ACAD) Pilot Study: Vietnamese Americans

Alzheimer disease and associated disorders, 2024-07, Vol.38 (3), p.277

2024

Volltextzugriff (PDF)

Value-Generating Exploratory Trials in Neurodegenerative Dementias

Neurology, 2021-05, Vol.96 (20), p.944-954

2021

Volltextzugriff (PDF)

Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia

Alzheimer disease and associated disorders, 2020-10, Vol.34 (4), p.357-359

2020

Volltextzugriff (PDF)

Periventricular hyperintensities are associated with elevated cerebral amyloid

Neurology, 2016-02, Vol.86 (6), p.535-543

2016

Volltextzugriff (PDF)

Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial

EBioMedicine, 2024-01, Vol.99, p.104923-104923, Article 104923

2024

Volltextzugriff (PDF)

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers

Neurology, 2013-10, Vol.81 (15), p.1322-1331

2013

Volltextzugriff (PDF)

Superficial Siderosis : A Potential Diagnostic Marker of Cerebral Amyloid Angiopathy in Alzheimer Disease

Stroke (1970), 2008-10, Vol.39 (10), p.2894-2897

2008

Volltextzugriff (PDF)

Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

Pharmacogenetics and genomics, 2008-04, Vol.18 (4), p.289-298

2008

Volltextzugriff (PDF)

Activities of daily living in moderate-to-severe alzheimer disease : An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment

Alzheimer disease and associated disorders, 2006-10, Vol.20 (4), p.263-268

2006

Volltextzugriff (PDF)

Cognition, function, and caregiving time patterns in patients with mild-to-moderate alzheimer disease : A 12-month analysis

Alzheimer disease and associated disorders, 2005, Vol.19 (1), p.29-36

2005

Volltextzugriff (PDF)

Rates of Cognitive Change in Alzheimer Disease: Observations Across a Decade of Placebo-controlled Clinical Trials With Donepezil

Alzheimer disease and associated disorders, 2009-10, Vol.23 (4), p.357-364

2009

Volltextzugriff (PDF)

Neurobehavioral characterization of adult-onset Alexander disease: A family study

Neurology. Clinical practice, 2017-10, Vol.7 (5), p.425-429

2017

Volltextzugriff (PDF)

Dropouts and refusals in observational studies: lessons for prevention trials

Neurology, 2006-11, Vol.67 (9 Suppl 3), p.S17

2006

Volltextzugriff (PDF)

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

Pharmacogenetics and genomics, 2008-04, Vol.18 (4), p.289-298

2008

Volltextzugriff (PDF)

Neurobehavioral characterization of adult-onset Alexander disease: A family study

Neurology. Clinical practice, 2017, Vol.7 (5), p.425-429

2017

Volltextzugriff (PDF)

Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

Journal of internal medicine, 2014-03, Vol.275 (3), p.251-283

2014

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(87)
Berichte
(1)
Reviews
(1)

Sprache

Englisch
(89)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)

Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency

Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers

Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features

Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression: A Two-Step Pilot Study

Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults

Asian Cohort for Alzheimer Disease (ACAD) Pilot Study: Vietnamese Americans

Value-Generating Exploratory Trials in Neurodegenerative Dementias

Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia

Periventricular hyperintensities are associated with elevated cerebral amyloid

Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers

Superficial Siderosis : A Potential Diagnostic Marker of Cerebral Amyloid Angiopathy in Alzheimer Disease

Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

Activities of daily living in moderate-to-severe alzheimer disease : An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment

Cognition, function, and caregiving time patterns in patients with mild-to-moderate alzheimer disease : A 12-month analysis

Rates of Cognitive Change in Alzheimer Disease: Observations Across a Decade of Placebo-controlled Clinical Trials With Donepezil

Neurobehavioral characterization of adult-onset Alexander disease: A family study

Dropouts and refusals in observational studies: lessons for prevention trials

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

Neurobehavioral characterization of adult-onset Alexander disease: A family study

Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

Aktive Filter

Suchergebnisse filtern